[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355996-105":59,"doc-detail-355996-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","venom-derived-enzyme-inhibitors-as-anticancer-agents-review","Venom-Derived Enzyme Inhibitors as Anticancer Agents - Review","","Animal venoms provide an exceptional but underexploited biochemical resource for anticancer drug discovery. This review analyzes venom-derived enzyme inhibitors as emerging anticancer agents, focusing on chemical diversity, structure–activity relationships, molecular targets, and mechanistic pathways. Venom-derived peptides and proteins bind strongly due to disulfide-rich rigidity, enabling selective modulation of cancer-associated enzymes such as matrix metalloproteinases, phospholipases A2, serine proteases, and kinases. Target inhibition can suppress angiogenesis, matrix remodeling, metastasis, and trigger apoptosis via mechanisms including reactive oxygen species generation. Computational deep learning, docking, and molecular dynamics accelerate peptide–receptor mapping and guide rational design. Clinical translation faces pharmacokinetic instability, rapid proteolysis, and systemic toxicity; integrating optimized scaffolds with nanocarriers or liposomal delivery offers a practical route to next-generation venom-inspired therapies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/venom-derived-enzyme-inhibitors-as-anticancer-agents-review/355996/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/venom-derived-enzyme-inhibitors-as-anticancer-agents-review/355996.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What makes venom-derived enzyme inhibitors promising anticancer agents?","Question",{"text":113,"@type":114},"They combine strong binding capability and structural rigidity with the ability to selectively modulate cancer-associated enzymes, disrupting angiogenesis, extracellular matrix remodeling, and metastasis while promoting apoptosis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which cancer-related molecular targets are highlighted in the review?",{"text":118,"@type":114},"Targets include matrix metalloproteinases, phospholipases A2, serine proteases, and kinases, along with other venom-derived components described as acting on receptors, ion channels, and enzymes.",{"name":120,"@type":111,"acceptedAnswer":121},"What computational methods are discussed for advancing discovery?",{"text":122,"@type":114},"Deep learning algorithms, molecular docking, and molecular dynamics simulations are described as accelerating mapping of peptide–receptor interactions and supporting rational drug design.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355996,1790182075,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":29,"preview_urls":147},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Review  \nVenom-Derived Enzyme Inhibitors as Anticancer Agents: Structure–Activity Relationships, Molecular Targets and Mechanistic Insights  \nAyorinde Victor Ogundele 1, *, Geetmani Singh Nongthombam 2, Adanna D. Nwagu 3, Héctor Hernán Silva 1 and Oluwatoyin Adenike Fabiyi 4  \nAcademic Editors: Stela Dimitrova, Ana M. Dobreva and Petko Denev  \nReceived: 24 May 2026  \nRevised: 30 June 2026  \nAccepted: 1 July 2026  \nPublished: 7 July 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Departamento de Ciencias Basicas, Facultad de Medicina, Universidad de La Frontera, Temuco 4780000, Chile; [hector.silva@ufrontera.cl](hector.silva@ufrontera.cl)  \n2 Department of Chemistry (RSAPS), The Assam Royal Global University, Guwahati 781035, Assam, India  \n3 Department of Chemistry, Universidad Tecnica Federico Santa Maria, Valparaíso 2340000, Chile  \n4 Department of Crop Protection, Faculty of Agriculture, University of Ilorin, Ilorin 240003, Nigeria  \n* [Correspondence: vicshow2001@gmail.com or ayorinde.ogundele@ufrontera.cl](Correspondence: vicshow2001@gmail.com or ayorinde.ogundele@ufrontera.cl)  \nAbstract  \nAnimal venoms represent an extraordinary, yet largely untapped, biochemical reservoir for oncological drug discovery. This review provides a comprehensive analysis of venomderived enzyme inhibitors as emerging anticancer agents, emphasizing their chemical diversity, structure–activity relationships (SAR), molecular targets, and mechanistic pathways. Venom-derived peptides and proteins exhibit exceptional binding affinity and structural rigidity, characteristics frequently enforced by conserved disulfide networks. This specific architecture allows them to selectively modulate critical cancer-associated enzymes, including matrix metalloproteinases, phospholipases A 2, serine proteases, and kinases. Inhibiting these highly specific targets successfully disrupts tumour angiogenesis, extracellular matrix remodelling, and metastatic dissemination, while simultaneously inducing apoptosis through unique pathways such as reactive oxygen species generation. Modern computational approaches, encompassing deep learning algorithms, molecular docking, and molecular dynamics simulations, are substantially accelerating and transforming the discovery pipeline by rapidly mapping intricate peptide–receptor interactions and guiding rational drug design. Translating these potent molecules into clinical therapeutics remains heavily challenged by pharmacokinetic instability, rapid proteolytic degradation, and systemic toxicity. The integration of computationally optimized scaffolds with advanced targeted delivery platforms, such as nanocarriers and liposomal encapsulation, offers a highly viable strategy to overcome these barriers, ultimately paving the way for next-generation, venom-inspired cancer therapies.  \nKeywords: animal venoms; venom-derived enzyme inhibitors; anticancer agents; structureactivity relationships; molecular targets; matrix metalloproteinases; phospholipase A 2  \n1. Introduction  \nCancer remains a leading global health challenge, accounting for approximately one in six deaths worldwide [1] . Despite significant advances in diagnosis and treatment, conventional therapeutic approaches such as chemotherapy, radiotherapy, and targeted therapies are often limited by systemic toxicity, off-target effects, and the emergence of drug resistance [2]. These limitations not only compromise therapeutic efficacy but also adversely  \naffect patient quality of life. Consequently, there is a growing demand for alternative or complementary strategies that combine high selectivity with reduced toxicity, thereby improving clinical outcomes.  \nNatural products have historically played a central role in anticancer drug discovery, providing structurally diverse and biologically active compounds w","cbCaiazYD0jXDMYR","https://ap.wps.com/l/cbCaiazYD0jXDMYR","pdf",15227695,54,"English","# Abstract\n# Keywords\n# 1. Introduction\n## Cancer burden and treatment limitations\n## Natural products and venom as bioactive reservoirs\n## Venoms as complex biochemical libraries\n# Review scope and translational challenges","[{\"question\":\"What makes venom-derived enzyme inhibitors promising anticancer agents?\",\"answer\":\"They combine strong binding capability and structural rigidity with the ability to selectively modulate cancer-associated enzymes, disrupting angiogenesis, extracellular matrix remodeling, and metastasis while promoting apoptosis.\"},{\"question\":\"Which cancer-related molecular targets are highlighted in the review?\",\"answer\":\"Targets include matrix metalloproteinases, phospholipases A2, serine proteases, and kinases, along with other venom-derived components described as acting on receptors, ion channels, and enzymes.\"},{\"question\":\"What computational methods are discussed for advancing discovery?\",\"answer\":\"Deep learning algorithms, molecular docking, and molecular dynamics simulations are described as accelerating mapping of peptide–receptor interactions and supporting rational drug design.\"}]","Venom-Derived Enzyme Inhibitors as Anticancer Agents - Review | PDF",1790122183,136,[148,152,156,160,164,168],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35ddb59053646348c757cb205172054e.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5286f99dcdff7ecf8c5fbe51aa2b5db8.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2cab820ac6afcfcc76c1f9ed0fa8efd.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d7451f434f0ffea237b3deddc399dc3.webp",980,1385,{"page_no":24,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cac272ed64ed34a0bd271a38c4d7727f.webp",979,1384,{"page_no":29,"url":169,"width":170,"height":171},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/94edee00efd1af44c9188e7c60cfe23d.webp",978,1383]